{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:38:25Z","timestamp":1792175905500,"version":"4.4.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Liver Transpl"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>Acute kidney injury (AKI) in the setting of cirrhosis (hepatorenal syndrome [HRS]\u2013AKI) is a severe and often fatal complication of end\u2010stage liver disease. The goals of treatment are to reverse renal failure and prolong survival in patients who are critically ill. However, interventions have limited efficacy, and mortality rates remain high. In the United States, the mainstay of pharmacologic therapy consists of the off\u2010label use of vasoconstrictive agents in combination with plasma expanders, a strategy that produces modest effects. Liver transplantation is the ultimate solution but is only an option in a minority of patients because contraindications to transplantation are common and organ availability is limited. Renal replacement therapy is a temporary option but is known to confer an extremely poor short\u2010term prognosis in patients with HRS\u2010AKI and at best serves as a bridge to liver transplantation for the minority of patients who are transplantation candidates. The high mortality rate associated with HRS\u2010AKI in the United States is a reflection of the suboptimal standard of care. Improved therapeutic options to treat HRS\u2010AKI are sought. Terlipressin is a drug approved in Europe for treatment of HRS\u2010AKI and supported by recommendations for first\u2010line therapy by some liver societies and experts around the world. This review article will discuss the substantial unmet medical need associated with HRS\u2010AKI and the potential benefits if terlipressin was approved in the United States.<\/jats:p>","DOI":"10.1002\/lt.26072","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T02:05:48Z","timestamp":1618365948000},"page":"1191-1202","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":48,"title":["The Current Management of Hepatorenal Syndrome\u2013Acute Kidney Injury in the United States and the Potential of Terlipressin"],"prefix":"10.1097","volume":"27","author":[{"given":"Steven L.","family":"Flamm","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Northwestern University Feinberg School of Medicine,Chicago,IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Transplant Institute,Henry Ford Hospital,Detroit,MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-0897","authenticated-orcid":false,"given":"Hani M.","family":"Wadei","sequence":"additional","affiliation":[{"name":"Department of Transplantation,Mayo Clinic,Jacksonville,FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology,Weill Cornell Medicine,New York,NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Kugelmas","sequence":"additional","affiliation":[{"name":"Hepatology and Research,South Denver Gastroenterology,Englewood,CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Samaniego\u2010Picota","sequence":"additional","affiliation":[{"name":"Department of Transplant Nephrology,Henry Ford Health System,Detroit,MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[{"name":"Multivisceral Transplant Unit, Department of Surgery, Oncology, and Gastroenterology,Padua University Hospital,Padua,Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Poordad","sequence":"additional","affiliation":[{"name":"University of Texas Health San Antonio, Texas Liver Institute,San Antonio,TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sammy","family":"Saab","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Surgery,David Geffen School of Medicine at University of California Los Angeles,Los Angeles,CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"lt26072-bib-0001-20250824","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14218\/JCTH.2015.00015","article-title":"Acute kidney injury in patients with cirrhosis","volume":"3","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"lt26072-bib-0002-20250824","doi-asserted-by":"crossref","first-page":"14642","DOI":"10.3748\/wjg.v20.i40.14642","article-title":"Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"lt26072-bib-0003-20250824","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semnephrol.2018.10.002","article-title":"Epidemiology, pathophysiology, and management of hepatorenal syndrome","volume":"39","year":"2019","journal-title":"Semin Nephrol"},{"key":"lt26072-bib-0004-20250824","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"lt26072-bib-0005-20250824","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1099\/jmm.0.2008\/001867-0","article-title":"Bacterial DNA and its consequences in patients with cirrhosis and culture\u2010negative, non\u2010neutrocytic ascites","volume":"57","year":"2008","journal-title":"J Med Microbiol"},{"key":"lt26072-bib-0006-20250824","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0035-1564794","article-title":"Hepatorenal syndrome: a review of pathophysiology and current treatment options","volume":"32","year":"2015","journal-title":"Semin Intervent Radiol"},{"key":"lt26072-bib-0007-20250824","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/MCG.0000000000000208","article-title":"The epidemiology of cirrhosis in the United States: a population\u2010based study","volume":"49","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"lt26072-bib-0011-20250824","first-page":"165","article-title":"Annual summary with detailed diagnosis and procedure data","volume":"13","year":"2007","journal-title":"Vital Health Stat"},{"key":"lt26072-bib-0012-20250824","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jim-d-15-00181","article-title":"Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002\u20102012","volume":"64","year":"2016","journal-title":"J Invest Med"},{"key":"lt26072-bib-0013-20250824","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"lt26072-bib-0014-20250824","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","year":"1993","journal-title":"Gastroenterology"},{"key":"lt26072-bib-0015-20250824","article-title":"Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: a prospective cohort study","volume":"2015","year":"2015","journal-title":"Int J Nephrol"},{"key":"lt26072-bib-0016-20250824","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","year":"2005","journal-title":"Hepatology"},{"key":"lt26072-bib-0017-20250824","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1053\/gast.2002.33575","article-title":"Hepatorenal syndrome in cirrhosis: pathogenesis and treatment","volume":"122","year":"2002","journal-title":"Gastroenterology"},{"key":"lt26072-bib-0018-20250824","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","year":"2005","journal-title":"Hepatology"},{"key":"lt26072-bib-0019-20250824","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/j.ajkd.2018.09.006","article-title":"Burden of care and quality of life among caregivers for adults receiving maintenance dialysis: a systematic review","volume":"73","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"lt26072-bib-0020-20250824","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13696998.2019.1580201","article-title":"The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records","volume":"22","year":"2019","journal-title":"J Med Econ"},{"key":"lt26072-bib-0021-20250824","first-page":"1310","article-title":"Diagnosis, prevention and treatment of the hepatorenal syndrome in cirrhosis a consensus workshop of the International Ascites Club","volume":"56","year":"2007","journal-title":"Gut"},{"key":"lt26072-bib-0022-20250824","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"lt26072-bib-0023-20250824","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","year":"2011","journal-title":"J Hepatol"},{"key":"lt26072-bib-0024-20250824","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","year":"2019","journal-title":"J Hepatol"},{"key":"lt26072-bib-0025-20250824","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4254\/wjh.v8.i34.1497","article-title":"Fractional excretion of sodium in hepatorenal syndrome: clinical and pathological correlation","volume":"8","year":"2016","journal-title":"World J Hepatol"},{"key":"lt26072-bib-0026-20250824","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","article-title":"The evaluation of renal function and disease in patients with cirrhosis","volume":"52","year":"2010","journal-title":"J Hepatol"},{"key":"lt26072-bib-0027-20250824","first-page":"1168","article-title":"Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels","volume":"59","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"lt26072-bib-0028-20250824","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/gfaa152","article-title":"Cystatin C to predict renal disease and cardiovascular risk","volume":"36","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"lt26072-bib-0029-20250824","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepato\u2010renal syndrome post liver transplantation","volume":"21","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"lt26072-bib-0030-20250824","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"lt26072-bib-0032-20250824","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2012.06.024","article-title":"Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"lt26072-bib-0033-20250824","first-page":"488","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"40","year":"2011","journal-title":"Gastroenterology"},{"key":"lt26072-bib-0034-20250824","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1111\/ajt.13408","article-title":"A multistep, consensus\u2010based approach to organ allocation in liver transplantation: toward a \u201cblended principle model.\u201d","volume":"15","year":"2015","journal-title":"Am J Transplant"},{"key":"lt26072-bib-0035-20250824","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamasurg.2017.1673","article-title":"Analysis of survival after initiation of continuous renal replacement therapy in a surgical intensive care unit","volume":"152","year":"2017","journal-title":"JAMA Surg"},{"key":"lt26072-bib-0036-20250824","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00003246-199301000-00011","article-title":"Iatrogenic complications in adult intensive care units: a prospective two\u2010center study","volume":"21","year":"1993","journal-title":"Crit Care Med"},{"key":"lt26072-bib-0037-20250824","doi-asserted-by":"crossref","first-page":"C124","DOI":"10.12968\/hmed.2019.80.8.C124","article-title":"Renal replacement therapy for acute kidney injury in intensive care","volume":"80","year":"2019","journal-title":"Br J Hosp Med"},{"key":"lt26072-bib-0038-20250824","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/lt.22008","article-title":"Pretransplant predictors of recovery of renal function after liver transplantation","volume":"16","year":"2010","journal-title":"Liver Transpl"},{"key":"lt26072-bib-0039-20250824","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2215\/CJN.09600912","article-title":"Short\u2010term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone","volume":"8","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"lt26072-bib-0041-20250824","first-page":"13","article-title":"Norepinephrine versus terlipressin in patients with type 1 hepatorenal syndrome refractory to treatment with octreotide, midodrine, and albumin (a prospective randomized comparative study)","volume":"7","year":"2013","journal-title":"Egypt J Cardiothorac Anesth"},{"key":"lt26072-bib-0042-20250824","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.gtc.2011.06.011","article-title":"Hepatorenal syndrome: do the vasoconstrictors work?","volume":"40","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"lt26072-bib-0043-20250824","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"lt26072-bib-0044-20250824","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/gast.2001.22529","article-title":"Octreotide potentiates PKC\u2010dependent vasoconstrictors in portal\u2010hypertensive and control rats","volume":"120","year":"2001","journal-title":"Gastroenterology"},{"key":"lt26072-bib-0045-20250824","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1440-1746.2009.05873.x","article-title":"Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis","volume":"24","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"lt26072-bib-0047-20250824","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"lt26072-bib-0048-20250824","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"lt26072-bib-0049-20250824","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta\u2010analysis","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"lt26072-bib-0050-20250824","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1159\/000375346","article-title":"The treatment of hepatorenal syndrome","volume":"33","year":"2015","journal-title":"Dig Dis"},{"key":"lt26072-bib-0051-20250824","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrgastro.2015.174","article-title":"The evolving concept of acute kidney injury in patients with cirrhosis","volume":"12","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"lt26072-bib-0052-20250824","article-title":"Hepatorenal syndrome: outcome of response to therapy and predictors of survival","volume":"2015","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"lt26072-bib-0053-20250824","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","year":"2002","journal-title":"Gastroenterology"},{"key":"lt26072-bib-0054-20250824","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of hepatorenal syndrome type 1","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"key":"lt26072-bib-0055-20250824","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"70","year":"2021","journal-title":"Gut"},{"key":"lt26072-bib-0056-20250824","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/apt.14052","article-title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT\u20100401 and REVERSE randomised clinical studies","volume":"45","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"lt26072-bib-0057-20250824","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double\u2010blind, placebo\u2010controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","year":"2008","journal-title":"Gastroenterology"},{"key":"lt26072-bib-0058-20250824","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"lt26072-bib-0059-20250824","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cgh.2016.07.016","article-title":"Terlipressin improves renal function and reverses hepatorenal syndrome in patients with systemic inflammatory response syndrome","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"lt26072-bib-0061-20250824","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1681\/ASN.20203110S175d","article-title":"Treatment of hepatorenal syndrome type 1 with terlipressin reduces need for renal replacement therapy after liver transplantation","volume":"31","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"lt26072-bib-0062-20250824","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1681\/ASN.20203110S115b","article-title":"Terlipressin improves renal replacement therapy\u2013free survival in hepatorenal syndrome type 1","volume":"31","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"lt26072-bib-0063-20250824","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/lt.22395","article-title":"Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1","volume":"17","year":"2011","journal-title":"Liver Transpl"},{"key":"lt26072-bib-0064-20250824","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/MEG.0b013e32833a4822","article-title":"Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis","volume":"22","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"lt26072-bib-0065-20250824","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00535-011-0485-8","article-title":"The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open label, explorative study","volume":"47","year":"2012","journal-title":"J Gastroenterol"},{"key":"lt26072-bib-0066-20250824","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1499-3872(12)60204-5","article-title":"Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome","volume":"11","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"lt26072-bib-0068-20250824","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMe2034425","article-title":"Terlipressin and Intravenous albumin in advanced cirrhosis\u2014friend and foe","volume":"384","year":"2021","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1002\/lt.26367","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lt.26072","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/lt.26072","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/lt.26072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T21:05:41Z","timestamp":1756069541000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/lt.26072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.26072","relation":{},"ISSN":["1527-6465","1527-6473"],"issn-type":[{"value":"1527-6465","type":"print"},{"value":"1527-6473","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]},"assertion":[{"value":"2021-01-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}